teriparatide sold brand name forteo form parathyroid hormone pth consisting first nterminus amino acids bioactive portion effective anabolic promoting bone formation used treatment forms teriparatide recombinant human parathyroid hormone analog pth identical sequence nterminal amino acids acid human parathyroid teriparatide indicated treatment postmenopausal women increase bone mass men primary hypogonadal treatment men women osteoporosis associated sustained systemic glucocorticoid effective growing bone eg increase bone density spine one reducing risk fragility teriparatide cuts risk hip fracture half reduce risk arm wrist teriparatide contraindicated open epiphyses metabolic bone diseases pagets disease bone bone metastases history skeletal malignancies prior external beam implant radiation therapy involving animal studies one human case report found potentially associated developing osteosarcoma test subjects two years adverse effects teriparatide include headache nausea dizziness limb teriparatide theoretical risk osteosarcoma found rat studies confirmed may unlike humans rat bones grow entire tumors found rat studies located end bones grew injections nine years market two cases osteosarcoma risk considered fda extremely rare slightly incidence population years old teriparatide portion human parathyroid hormone pth amino acid sequence complete molecule containing amino acids endogenous pth primary regulator calcium phosphate metabolism bone kidney pth increases serum calcium partially accomplishing increasing bone resorption thus chronically elevated pth deplete bone stores however intermittent exposure pth activate osteoblasts osteoclasts thus oncedaily injections teriparatide net effect stimulating new bone formation leading increased bone mineral teriparatide approved medical use united states teriparatide forteo approved fda november treatment osteoporosis men postmenopausal women high risk october us fda approved recombinant teriparatide product brand name recombinant teriparatide sold eli lilly company brand names forteo forsteo june alvogen inc pfenex incs commercialization partner launched teriparatide injection bonsity united states teriparatide injection developed pfenex inc approved us food drug administration fda october teriparatide injection pharmaceutically equivalent forteo active ingredient strength dosage form route administration shown comparable bioavailability characteristics allowed product approved nda forteo reference drug may provide lowercost teriparatide option increasing bone density patients high risk fracture fdaapproved indications forteo means used patients forteo including new patients currently responding teriparatide approved medical use european union june synthetic teriparatide teva generics authorized marketing european biosimilar product gedeon richter plc authorized european october us fda approved recombinant teriparatide june committee medicinal products human use chmp european medicines agency ema recommended approval biosimilar products qutavina namelivogiva epar qutavina livogiva approved medical use european union august osnuvo approved medical use canada january sondelbay approved medical use european union march november committee medicinal products human use chmp adopted positive opinion recommending granting marketing authorization medicinal product kauliv intended treatment applicant medicinal product strides pharma kauliv approved medical use european union february teriparatide undergoing clinical trial zoledronic acid treatment osteogenesis imperfecta reduce risk broken combined teriparatide denosumab increased bmd either agent alone reported approved therapies combination treatment might therefore useful treat patients high risk fracture increasing bmd however evidence fracture rate reduction patients taking teriparatide denosumab combination first trial published leder et al lancet data subsequently published jcem trial post menopausal osteoporotic women demonstrating larger bone mineral density increases spine hip combination therapy compared either drug httpsenwikipediaorgwikiteriparatide